Xuefeng Liu

6.8k total citations
21 papers, 528 citations indexed

About

Xuefeng Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Xuefeng Liu has authored 21 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Hepatology. Recurrent topics in Xuefeng Liu's work include Cancer, Lipids, and Metabolism (4 papers), Renal cell carcinoma treatment (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Xuefeng Liu is often cited by papers focused on Cancer, Lipids, and Metabolism (4 papers), Renal cell carcinoma treatment (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Xuefeng Liu collaborates with scholars based in China, Ethiopia and United States. Xuefeng Liu's co-authors include Hui‐Chuan Sun, Xiao‐Dong Zhu, Zhao–You Tang, Xiao‐Long Li, Jian Xue, Shi-Zhe Zhang, Su‐Juan Kuang, Jiumin Liu, Long-Hai Feng and Yongzhi Wang and has published in prestigious journals such as Chemical Communications, Free Radical Biology and Medicine and Materials Science and Engineering A.

In The Last Decade

Xuefeng Liu

21 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuefeng Liu China 11 265 195 127 115 55 21 528
Jinggang Mo China 13 246 0.9× 178 0.9× 148 1.2× 87 0.8× 51 0.9× 36 516
Tao Jia China 14 408 1.5× 131 0.7× 68 0.5× 90 0.8× 47 0.9× 60 716
Xiaoxi Fan China 16 403 1.5× 243 1.2× 79 0.6× 92 0.8× 31 0.6× 36 661
Hongxia Cheng China 16 406 1.5× 136 0.7× 71 0.6× 164 1.4× 31 0.6× 51 676
Chengzhi Huang China 13 218 0.8× 144 0.7× 97 0.8× 128 1.1× 74 1.3× 38 475
Allen Zhang United States 10 397 1.5× 141 0.7× 76 0.6× 133 1.2× 27 0.5× 16 565
Jiazhang Wei China 14 324 1.2× 194 1.0× 75 0.6× 126 1.1× 46 0.8× 46 606
Chunhui Cui China 15 319 1.2× 225 1.2× 75 0.6× 94 0.8× 46 0.8× 42 578

Countries citing papers authored by Xuefeng Liu

Since Specialization
Citations

This map shows the geographic impact of Xuefeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Liu more than expected).

Fields of papers citing papers by Xuefeng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Liu. The network helps show where Xuefeng Liu may publish in the future.

Co-authorship network of co-authors of Xuefeng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefeng Liu. A scholar is included among the top collaborators of Xuefeng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefeng Liu. Xuefeng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McKenney, Jesse K., Reza Alaghehbandan, Xuefeng Liu, et al.. (2025). Atypical Intraductal Proliferation in Prostate Needle Core Biopsy. The American Journal of Surgical Pathology. 49(5). 515–522. 4 indexed citations
2.
Liu, Xuefeng, et al.. (2024). Analysis on the mechanism of titanium plate pretreated by ultrasonic shot peening in improving interfacial shear strength of Ti/Al laminated composite. Materials Science and Engineering A. 917. 147393–147393. 8 indexed citations
3.
Liu, Xuefeng, Xiao‐Dong Zhu, Long-Hai Feng, et al.. (2022). Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse model. Experimental Hematology and Oncology. 11(1). 20–20. 16 indexed citations
4.
Du, Yuting, Ying Long, Wei Tang, et al.. (2022). Prooxidative inhibition against NF-κB-mediated inflammation by pharmacological vitamin C. Free Radical Biology and Medicine. 180. 85–94. 26 indexed citations
5.
Wang, Qi, Lin Dong, Xuefeng Liu, et al.. (2022). Engineering piperlongumine-inspired analogs as Nrf2-dependent neuroprotectors against oxidative damage by an electrophilicity-based strategy. Free Radical Biology and Medicine. 194. 298–307. 3 indexed citations
6.
7.
Feng, Long-Hai, Hui‐Chuan Sun, Xiao‐Dong Zhu, et al.. (2021). Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma. Annals of Translational Medicine. 9(3). 207–207. 11 indexed citations
8.
Zhang, Shi-Zhe, Xiao‐Dong Zhu, Long-Hai Feng, et al.. (2021). PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma. Experimental Hematology and Oncology. 10(1). 25–25. 49 indexed citations
9.
Feng, Long-Hai, Hui‐Chuan Sun, Xiao‐Dong Zhu, et al.. (2020). Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy. European Journal of Surgical Oncology. 47(3). 681–689. 9 indexed citations
10.
Li, Xiao‐Long, Xiao‐Dong Zhu, Xuefeng Liu, et al.. (2020). A prospective study of the effect of terlipressin on portal vein pressure and clinical outcomes after hepatectomy: A pilot study. Surgery. 167(6). 926–932. 8 indexed citations
11.
Li, Kangshuai, Xiao‐Dong Zhu, Hongda Liu, et al.. (2020). NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma. Cell Death and Disease. 11(5). 335–335. 45 indexed citations
12.
Liu, Xuefeng, Zhiqiang Chen, Yu Meng, et al.. (2019). Safety of Simultaneous Hepatectomy and Splenectomy in the Treatment of Hepatocellular Carcinoma Complicated with Hypersplenism: A Meta-analysis. Gastroenterology Research and Practice. 2019. 1–17. 10 indexed citations
13.
Liu, Xuefeng, et al.. (2019). Effects of dexamethasone combined with ambroxol hydrochloride on T-Cell subsets and hearing in patients with secretory otitis media.. PubMed. 32(3 Special). 1437–1440. 2 indexed citations
14.
Chen, Liang, Lushun Yuan, Yongzhi Wang, et al.. (2017). Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma. International Journal of Biological Sciences. 13(11). 1361–1372. 96 indexed citations
15.
Wang, Zhijun, et al.. (2016). Precision or Personalized Medicine for Cancer Chemotherapy: Is there a Role for Herbal Medicine. Molecules. 21(7). 889–889. 22 indexed citations
16.
Liu, Jiumin, et al.. (2015). Inhibition of LDHA suppresses tumor progression in prostate cancer. Tumor Biology. 36(10). 8093–8100. 115 indexed citations
17.
Wang, Kefeng, Xiaonan Chen, Yunhong Zhan, et al.. (2013). Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma. Medical Oncology. 30(2). 574–574. 35 indexed citations
18.
Xu, Junhua, Fuping Gao, Xuefeng Liu, et al.. (2013). Supramolecular gelatin nanoparticles as matrix metalloproteinase responsive cancer cell imaging probes. Chemical Communications. 49(40). 4462–4462. 58 indexed citations
19.
Jia, Lili, et al.. (2012). Detection and application of PIS genetic deficiency gene in dairy goat. Hereditas (Beijing). 34(7). 895–900. 1 indexed citations
20.
Chai, Yourong, Yongzhen Pang, Kaijing Zuo, et al.. (2004). Isolation and Characterization of an IAA-responsive Gene fromGossypium barbadenseL.. DNA sequence. 15(1). 71–76. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinggang Mo Breakdown of academic impact, for papers by Tao Jia Breakdown of academic impact, for papers by Xiaoxi Fan Breakdown of academic impact, for papers by Hongxia Cheng Breakdown of academic impact, for papers by Chengzhi Huang Breakdown of academic impact, for papers by Allen Zhang Breakdown of academic impact, for papers by Jiazhang Wei Breakdown of academic impact, for papers by Chunhui Cui
Rankless by CCL
2026